Table 4.
IC50 (μM)
|
|||||
---|---|---|---|---|---|
HT-29 a | MCF-7 b | NCI-H460 c | SF268 d | IMR90 e | |
Hapalindole X (1) | 24.8 | 35.4 ± 2.8 | 23.0 ± 4.6 | 23.5 ± 9.5 | 113.2 ± 13.2 |
13-hydroxy dechlorofontonamide (3) | NA | >100 | >100 | >100 | >100 |
Hapalindole I | NA | >100 | 68.5 ± 11.0 | 93.1 ± 14.0 | >100 |
Hapalindole J | 28.6 | 43.7 ± 10.0 | 12.0 ± 1.9 | 16.9 ± 3.4 | 39.1 ± 6.6 |
Hapalindole A | 31.3 | 30.7 ± 7.1 | 17.0 ± 4.8 | 16.3 ± 7.1 | 39.1 ± 10.2 |
Hapalindole U | 52.6 | >100 | >100 | >100 | >100 |
Hapalindole C | 52.6 | >100 | 53.7 ± 15.5 | 88.6 ± 17.6 | >100 |
Hapalindole H | 10.8 | 16.3 ± 3.3 | 8.5 ± 3.7 | 10.6 ± 4.5 | 31.9 ± 11.6 |
Anhydrohapaloxindole A | NT | 56.7 ± 10.5 | 18.7 ± 6.2 | 26.0 ± 9.0 | 80.1 ± 24.5 |
Fischerindole L | 48.2 | 28.3 ± 8.1 | 15.1 ± 2.6 | 17.4 ± 8.6 | 46.3 ± 13.7 |
Camptothecin | NT | 0.08 ± 0.1 | 0.002 ± 0.0 | 0.07 ± 0.1 | 0.43 ± 0.5 |
Human colon adenocarcinoma.
Human breast carcinoma.
Human large cell lung carcinoma.
Human glioblastoma cancer cell.
Human lung fibroblast normal cell. IC50 values were obtained by averaging the results from three independent experiments. NT represents not tested. NA represents not active.